Johnson & Johnson suspends sales forecast for Covid vaccine
During Johnson & Johnson’s quarterly results call on Tuesday, the company halted sales predictions for its Covid-19 vaccine, citing a lack of demand compared to injections from Moderna and Pfizer. “Given global supply surplus and demand uncertainty, the Company is suspending COVID-19 Vaccine sales guidance,” J&J said in a statement, adding that the move will … Read more